Our Grow Together initiative involves Rubicon Research backing, with both capital and strategic support, seed and early-stage ventures founded by entrepreneurs and innovators. These ventures are not only in the traditional pharmaceutical domain, but also in allied domains involving application of emerging technologies like AI, continuous manufacturing, and big data in the pharmaceutical industry, to achieve our key goals of Innovation, Quality, and Care. Rubicon Research invites such entrepreneurs and innovators from across the globe, who are looking for financing and partnerships, to email their proposals to The proposals will be confidentially reviewed by the CEO’s office to evaluate their fit into the company’s stringent science criteria.